Condensed Statements of Stockholders' (Deficit)/Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at Dec. 31, 2021	$ 3	$ 328,958	$ (266,315)	$ (107)	$ 62,539
Balance (in shares) at Dec. 31, 2021	26,215,514
Increase (Decrease) in Stockholders' Equity
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)	21,417
Restricted Stock Units released for common stock not yet issued (in shares)	(21,417)
Stock-based compensation expense		2,077			2,077
Issuance of options in-lieu of bonus		441			441
Net loss			(23,121)		(23,121)
Other comprehensive income (loss)				27	27
Balance at Mar. 31, 2022	$ 3	331,476	(289,436)	(80)	41,963
Balance (in shares) at Mar. 31, 2022	26,215,514
Balance at Dec. 31, 2021	$ 3	328,958	(266,315)	(107)	62,539
Balance (in shares) at Dec. 31, 2021	26,215,514
Increase (Decrease) in Stockholders' Equity
Net loss					(48,978)
Balance at Jun. 30, 2022	$ 5	341,090	(315,293)	6	25,808
Balance (in shares) at Jun. 30, 2022	46,253,524
Balance at Mar. 31, 2022	$ 3	331,476	(289,436)	(80)	41,963
Balance (in shares) at Mar. 31, 2022	26,215,514
Increase (Decrease) in Stockholders' Equity
Issuance of common stock sold for cash, net of issuance costs	$ 2	5,966			5,968
Issuance of common stock sold for cash, net of issuance costs (in shares)	20,000,000
Exercise of prefunded warrants for common stock		1,417			1,417
Exercise of pre-funded warrants for common stock (in shares)	1,750,000
Exercise of prefunded warrants for common stock not yet issued (in shares)	(1,750,000)
Issuance of common stock for Restricted Stock released in prior periods under Equity Incentive Plan (in shares)	21,417
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)	16,593
Stock-based compensation expense		2,231			2,231
Net loss			(25,857)		(25,857)
Other comprehensive income (loss)				86	86
Balance at Jun. 30, 2022	$ 5	341,090	(315,293)	6	25,808
Balance (in shares) at Jun. 30, 2022	46,253,524
Balance at Dec. 31, 2022	$ 5	352,828	(348,823)	51	4,061
Balance (in shares) at Dec. 31, 2022	48,063,358
Increase (Decrease) in Stockholders' Equity
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)	50,203
Stock-based compensation expense		2,055			2,055
Net loss			(10,137)		(10,137)
Other comprehensive income (loss)				(51)	(51)
Balance at Mar. 31, 2023	$ 5	354,883	(358,960)		(4,072)
Balance (in shares) at Mar. 31, 2023	48,113,561
Balance at Dec. 31, 2022	$ 5	352,828	(348,823)	$ 51	$ 4,061
Balance (in shares) at Dec. 31, 2022	48,063,358
Increase (Decrease) in Stockholders' Equity
Exercise of stock options (in shares)					20,174
Net loss					$ (39,714)
Balance at Jun. 30, 2023	$ 6	384,197	(388,537)		(4,334)
Balance (in shares) at Jun. 30, 2023	62,119,466
Balance at Mar. 31, 2023	$ 5	354,883	(358,960)		(4,072)
Balance (in shares) at Mar. 31, 2023	48,113,561
Increase (Decrease) in Stockholders' Equity
Issuance of common stock and pre-funded warrants, net of issuance costs	$ 1	27,449			27,450
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)	9,735,731
Exercise of pre-funded warrants for common stock (in shares)	4,250,000
Exercise of stock options		22			22
Exercise of stock options (in shares)	20,174
Stock-based compensation expense		1,843			1,843
Net loss			(29,577)		(29,577)
Balance at Jun. 30, 2023	$ 6	$ 384,197	$ (388,537)		$ (4,334)
Balance (in shares) at Jun. 30, 2023	62,119,466